Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q3 2019 · 10-Q
Revenue$155.55M$155.55M+7.3% vs Q3 2018 Net Income$1.07M$1.07M−93.4% vs Q3 2018 EPS Diluted$0.04$0.04−93.0% vs Q3 2018 Gross Profit$21,569,000+8.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flowderived$12,646,000−37.7% Free Cash Flowderived-$1,910,000N/M Margins · derivedGross margin13.9%+0.2 pt vs Q3 2018
Operating margin2.1%−0.3 pt vs Q3 2018
Net margin0.7%−10.4 pt vs Q3 2018
ended Feb 24, 2019 · filed Apr 4, 2019 · 39 d after period end